Heterogeneity of Subsets in Glioblastoma Mediated by Smad3 Palmitoylation

A mutation in isocitrate dehydrogenase 1 was found to suppress the transforming growth factor-beta signaling pathway and E2F4 interacted with Smad3 to inhibit expression of mesenchymal markers.